|
1
|
Clemens JQ, Meenan RT, O'Keeffe Rosetti
MC, Gao SY and Calhoun EA: A. Incidence and clinical
characteristics of national institutes of health type III
prostatitis in the community. J Urol. 174:2319–2322.
2005.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Shoskes DA, Berger R, Elmi A, Landis JR,
Propert KJ and Zeitlin S: Chronic Prostatitis Collaborative
Research Network Study Group. Muscle tenderness in men with chronic
prostatitis/chronic pelvic pain syndrome: The chronic prostatitis
cohort study. J Urol. 179:556–560. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Pontari MA and Ruggieri MR: Mechanisms in
prostatitis/chronic pelvic pain syndrome. J Urol. 179 (Suppl
5):S61–S67. 2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Cai T, Verze P and Bjerklund Johansen TE:
The quality of life definition: Where are we going? Uro. 1:14–22.
2021.
|
|
5
|
Franco JV, Turk T, Jung JH, Xiao YT,
Iakhno S, Tirapegui FI, Garrote V and Vietto V: Pharmacological
interventions for treating chronic prostatitis/chronic pelvic pain
syndrome. Cochrane Database Syst Rev. 10(CD012552)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Franco JV, Turk T, Jung JH, Xiao YT,
Iakhno S, Garrote V and Vietto V: Non-pharmacological interventions
for treating chronic prostatitis/chronic pelvic pain syndrome.
Cochrane Database Syst Rev. 1(CD012551)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cai T, Verze P, La Rocca R, Anceschi U, De
Nunzio C and Mirone V: . The role of flower pollen extract in
managing patients affected by chronic prostatitis/chronic pelvic
pain syndrome: A comprehensive analysis of all published clinical
trials. BMC Urol. 17(32)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Salama AB and Abouelnaga WA: Effect of
radial shock wave on chronic pelvic pain syndrome/chronic
prostatitis. J Phys Ther Sci. 30:1145–1149. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li G and Man L: Low-intensity
extracorporeal shock wave therapy for III B chronic pelvic pain
syndrome. Transl Androl Urol. 9:1323–1328. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Strauss AC and Dimitrakov JD: New
treatments for chronic prostatitis/chronic pelvic pain syndrome.
Nat Rev Urol. 7:127–135. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhang J, Liang CZ, Shang X and Li H:
Chronic prostatitis/chronic pelvic pain syndrome: A disease or
symptom? current perspectives on diagnosis, treatment, and
prognosis. Am J Mens Health. 14(1557988320903200)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wu X, Cheng K, Xu C, Liu S, Sun Q, Yang Z,
Dai X and Li N: Mechanism of acupuncture and moxibustion on chronic
prostatitis/chronic pelvic pain syndrome: A narrative review of
animal studies. Pain Res Manag. 2021(2678242)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hu M, Wazir J, Ullah R, Wang W, Cui X,
Tang M and Zhou X: Phytotherapy and physical therapy in the
management of chronic prostatitis-chronic pelvic pain syndrome. Int
Urol Nephrol. 51:1081–1088. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Cai T, Anceschi U, Tamanini I, Verze P and
Palmieri A: Soybean extracts (glycine max) with curcuma, boswellia,
pinus and urtica are able to improve quality of life in patients
affected by CP/CPPS: Is the pro-inflammatory cytokine IL-8 level
decreasing the physiopathological link? Uro. 2:40–48. 2022.
|
|
15
|
Karlsen M, Hovden AO, Vogelsang P, Tysnes
BB and Appel S: Bromelain treatment leads to maturation of
monocyte-derived dendritic cells but cannot replace PGE2 in a
cocktail of IL-1β, IL-6, TNF-α and PGE2. Scand. J Immunol.
74:135–143. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gallelli L: Escin: A review of its
anti-edematous, antiinflammatory, and venotonic properties. Drug
Des Devel Ther. 13:3425–3437. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Badía X, García-Losa M and Dal-Ré R:
Ten-language translation and harmonization of the international
prostate symptom score: Developing a methodology for multinational
clinical trials. Eur Urol. 31:129–140. 1997.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Couper M, Tourangeau R, Conrad F and
Singer E: Evaluating the effectiveness of visual analog scales: A
web experiment. Soc Sci Comput Rev. 24:227–245. 2006.
|
|
19
|
Giubilei G, Mondaini N, Crisci A, Raugei
A, Lombardi G, Travaglini F, Del Popolo G and Bartoletti R: The
Italian version of the national institutes of health chronic
prostatitis symptom index. Eur Urol. 47:805–811. 2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cai T, Gallelli L, Cione E, Verze P,
Palmieri A, Mirone V, Bonkat G, Wagenlehner FM and Bjerklund
Johansen TE: The efficacy and tollerability of pollen extract in
combination with hyaluronic acid and vitamins in the management of
patients affected by chronic prostatitis/chronic pelvic pain
syndrome: A 26 weeks, randomized, controlled, single-blinded, phase
III study. Minerva Urol Nephrol: Mar 29, 2021 (Epub ahead of
print).
|
|
21
|
Cai T, Wagenlehner FM, Luciani LG,
Tiscione D, Malossini G, Verze P, Mirone V and Bartoletti R: Pollen
extract in association with vitamins provides early pain relief in
patients affected by chronic prostatitis/chronic pelvic pain
syndrome. Exp Ther Med. 8:1032–1038. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
European Association of Urology (EAU):
Guidelines on Chronic Pelvic Pain. EAU, Arnhem, 2020. https://uroweb.org/guideline/chronic-pelvic-pain/.
Accessed January 27, 2020.
|
|
23
|
Meares EM Jr and Stamey TA: The diagnosis
and management of bacterial prostatitis. Br J Urol. 44:175–179.
1972.PubMed/NCBI View Article : Google Scholar
|
|
24
|
World Medical Association (WMA): WMA
Declaration of Helsinki-Ethical Principles for Medical Research
Involving Human Subjects. WMA, Ferney-Voltaire, 2020. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/.
Accessed January 27, 2020.
|
|
25
|
Hale LP, Greer PK and Sempowski GD:
Bromelain treatment alters leukocyte expression of cell surface
molecules involved in cellular adhesion and activation. Clin
Immunol. 104:183–190. 2002.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zimmermann R, Cumpanas A, Miclea F and
Janetschek G: Extracorporeal shock wave therapy for the treatment
of chronic pelvic pain syndrome in males: A randomised,
double-blind, placebo-controlled study. Eur Urol. 56:418–424.
2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Pajovic B, Radojevic N, Dimitrovski A and
Vukovic M: Comparison of the efficiency of combined extracorporeal
shockwave therapy and triple therapy versus triple therapy itself
in Category III B chronic pelvic pain syndrome (CPPS). Aging Male.
19:202–207. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mykoniatis I, Kalyvianakis D, Zilotis F,
Kapoteli P, Fournaraki A, Poulios E and Hatzichristou D: Evaluation
of a low-intensity shockwave therapy for chronic prostatitis type
IIIb/chronic pelvic pain syndrome: A double-blind randomized
sham-controlled clinical trial. Prostate Cancer Prostatic Dis.
24:370–379. 2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kim KS, Choi YS, Bae WJ, Cho HJ, Ha US,
Hong SH, Lee JY, Ahn ST, Moon DG and Kim SW: Efficacy of
low-intensity extracorporeal shock wave therapy for the treatment
of chronic pelvic pain syndrome IIIb: A prospective-randomized,
double-blind, placebo-controlled study. World J Mens Health.
40:473–480. 2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Jeon SH, Zhu GQ, Kwon EB, Lee KW, Cho HJ,
Ha US, Hong SH, Lee JY, Bae WJ and Kim SW: Extracorporeal shock
wave therapy decreases COX-2 by inhibiting TLR4-NFκB pathway in a
prostatitis rat model. Prostate. 79:1498–1504. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li G and Man L: Low-intensity
extracorporeal shock wave therapy for male chronic pelvic pain
syndrome: A systematic review and meta-analysis. Transl Androl
Urol. 10:1202–1211. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Magistro G, Wagenlehner FM, Grabe M,
Weidner W, Stief CG and Nickel JC: Contemporary management of
chronic prostatitis/chronic pelvic pain syndrome. Eur Urol.
69:286–297. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Bakare AO and Owoyele BV: Bromelain
reduced pro-inflammatory mediators as a common pathway that mediate
antinociceptive and anti-anxiety effects in sciatic nerve ligated
Wistar rats. Sci Rep. 11(289)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Xin W, Zhang L, Sun F, Jiang N, Fan H,
Wang T, Li Z, He J and Fu F: Escin exerts synergistic
anti-inflammatory effects with low doses of glucocorticoids in vivo
and in vitro. Phytomedicine. 18:272–277. 2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Capasso F, Grandolini G and Izzo A:
Placebo effect. In: Phytotherapy. Springer, Milan, 2006.
|
